Pliant Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pliant Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11061
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pliant Therapeutics Inc (Pliant Therapeutics) is a biotechnology company that strives to discover, develop and commercialize treatments for fibrotic diseases. The company harnesses its capabilities in integrin biology, medicinal chemistry, clinical insight and TGF-ß modulation to block or reverse fibrosis by developing tissue specific inhibitors. It is developing a pipeline of cell-specific small molecule inhibitors of the pathological epithelial-to-mesenchymal-transition (EMT) process to help treat fibrotic disorders. Pliant Therapeutics is developing programs targeting idiopathic pulmonary fibrosis; liver, cardiac and renal fibrosis; and primary sclerosing cholangitis. The company also intends to create a patient registry for some specific areas of fibrotic disease to understand its natural progression and enable biomarker discovery for diagnosis. Pliant Therapeutics is headquartered in South San Francisco, California, the US.

Pliant Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pliant Therapeutics Raises USD62 Million in Series B Venture Financing 10
Pliant Therapeutics Raises USD45 Million in Series A Financing 12
Partnerships 13
Pliant Therapeutics Enters into Research Agreement with Cleveland Clinic 13
Licensing Agreements 14
Pliant Therapeutics Enters into Licensing Agreement with UC San Francisco 14
Pliant Therapeutics Inc – Key Competitors 15
Pliant Therapeutics Inc – Key Employees 16
Pliant Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
May 08, 2018: Pliant Therapeutics appoints Hoyoung Huh as Chairman and Eric Lefebvre as Chief Medical Officer 18
Sep 26, 2017: Pliant Appoints Katerina Leftheris, Ph.D., as Vice President of Chemistry and John Curnutte, M.D., Ph.D. to the Board of Directors 19
Clinical Trials 20
Nov 09, 2018: Pliant Therapeutics presents preclinical data on integrin inhibitors at The Liver Meeting 2018 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pliant Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pliant Therapeutics Raises USD62 Million in Series B Venture Financing 10
Pliant Therapeutics Raises USD45 Million in Series A Financing 12
Pliant Therapeutics Enters into Research Agreement with Cleveland Clinic 13
Pliant Therapeutics Enters into Licensing Agreement with UC San Francisco 14
Pliant Therapeutics Inc, Key Competitors 15
Pliant Therapeutics Inc, Key Employees 16

List of Figures
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pliant Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pliant Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Zincore Metals Inc:企業の戦略・SWOT・財務分析
    Zincore Metals Inc - Strategy, SWOT and Corporate Finance Report Summary Zincore Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • True Diagnostics Inc:製品パイプライン分析
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides trueDX platform technology including trueDX reader, trueDX software, trueDX-TSH test, trueDX-T4 test, trueDX-Gneg …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務情報
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Exorka GmbH:企業の戦略的SWOT分析
    Exorka GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Fluor Corporation (FLR):企業の財務・戦略的SWOT分析
    Fluor Corporation (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oswaldo Cruz Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research and development in biological sciences. It offers research programs and technological development projects in vaccines production, medications, drugs, reagents and diagnostic kits. The foundation provides research in experiment …
  • Intermediate Capital Group Plc:企業の戦略・SWOT・財務情報
    Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pharmacosmos AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務情報
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Golden Gate Capital:企業の戦略的SWOT分析
    Golden Gate Capital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Yingli Green Energy Holding Company Limited (YGE):企業の財務・戦略的SWOT分析
    Yingli Green Energy Holding Company Limited (YGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • Sanovas Inc:医療機器:M&Aディール及び事業提携情報
    Summary SanovasInc (Sanovas) is a developer of diagnostic solutions that develops access, imaging, measurement, therapeutic technologies and solutions for physician. The company provides imaging technologies, interventional lung, interventional ENT, and interventional uro and gyn products, among oth …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • Clean Diesel Technologies Inc (CDTI):企業の財務・戦略的SWOT分析
    Summary Clean Diesel Technologies Inc (CDTI) is a clean technology company that manufactures and distributes heavy duty diesel and light duty vehicle emissions control systems and products to automakers and retrofitters. The company's products include catalyst products, heavy duty diesel products, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆